Therapeutic Confirmatory Clinical Trial to Evaluate the Safety and Efficacy of "Hugeltox Inj." in Essential Blepharospasm

Clinical trial NCT01791881 · COMPLETED

Trial details

NCT number: NCT01791881
Sponsor: Hugel
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Essential Blepharospasm

Start date: 2008-04-01
Primary completion: 2009-05-01
Enrollment: 172

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.